missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SERC2 Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (77%), Rat (77%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52233 (PA5-52233. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SERINC2 (Serine Incorporator 2) is a Protein Coding gene. Diseases associated with SERINC2 include Rapp-Hodgkin Syndrome and Alcohol Dependence. Among its related pathways are Viral mRNA Translation and Metabolism. Gene Ontology (GO) annotations related to this gene include L-serine transmembrane transporter activity. An important paralog of this gene is SERINC1. [GeneCards]
Specifications
Specifications
| Accession Number | Q96SA4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 347735 |
| Name | Human SERC2 Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2310004K20Rik; AW121759; FKSG84; PRO0899; Serinc2; Serine incorporator 2; TDE2; TDE2L; tumor differentially expressed protein 2; Tumor differentially expressed protein 2-like; UNQ263/PRO300 |
| Common Name | SERC2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu